Profile
Yang Alex Keun Mo is listed as the Chief Executive Officer of Polaryx Therapeutics, Inc. in the most recent SEC filing dated May 29, 2026. Beyond this filing, public details about his education, career history, or prior roles are not provided in the context you supplied. He is described in this context as leading the company in its biotechnology-focused activities and strategic direction as of the filing date.
| Role | Chief Executive Officer, Director, 10% Owner |
|---|
| Notability | 42/100 |
|---|
Board memberships
- Polaryx Therapeutics, Inc.
Awards & honors
- Appointed Chief Executive Officer of Polaryx Therapeutics, Inc. as per the 2026 SEC filing
Frequently Asked Questions
Who is Yang Alex Keun Mo?
Yang Alex Keun Mo is listed as the Chief Executive Officer of Polaryx Therapeutics, Inc. in the most recent SEC filing dated May 29, 2026. Beyond this filing, public details about his education, career history, or prior roles are not provided in the context you supplied. He is described in this context as leading the company in its biotechnology-focused activities and strategic…
How many SEC Form 4 filings has Yang Alex Keun Mo submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Yang Alex Keun Mo been buying or selling stock?
Recorded transactions: 1 open-market purchases ($360K) and 0 open-market sales () across all tracked filings.
Where can I see all of Yang Alex Keun Mo's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.